Primary Job Title Senior Vice President of Commercial Development Primary Organization 
Napo Pharmaceuticals
Location Washington, District of Columbia, United States Regions Washington DC Metro Area, Southern US Gender Female
LinkedIn View on LinkedIn
Katie MacFarlane is an experienced pharmaceutical executive with over 25 years in the industry, including senior level roles in drug development, marketing, and sales management. Katie played a key role in the launch of many pharmaceutical brands, most notably Lipitor®, Celexa®, and Loestrin® 24. Katie’s GI experience includes clinical research in
IBS (Librax®) and obesity (Xenical®), as well as consultation on Amitiza® (constipation and IBS) and crofelemer. Katie has held senior roles including Chief Commercial Officer of Agile Therapeutics, Vice President of Women’s Health and New Product Planning at Warner Chilcott, and Sr. Director of Marketing at Parke-Davis/Warner-Lambert.
Katie received her BS and PharmD degrees from Purdue University and completed a Postdoctoral Fellowship with Rutgers University and Hoffmann-LaRoche. She was named a Distinguished Alumna in 1999 and was awarded the Eaton Entrepreneur of the Year in 2012 by the Purdue University School of Pharmacy. Katie currently serves on the Purdue Pharmacy Dean’s Advisory Council, is a Founding Member and Advisor to IPhO, and serves as an Affiliate Faculty member in the Department of Pharmacy Practice at Purdue University. She is a member of the Board of Directors of RespireRx Pharmaceuticals and of INMED Partnerships for Children.
